BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2176688)

  • 1. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
    Ballard SA; Ellis SW; Kelly SL; Troke PF
    J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.
    Ballard SA; Kelly SL; Ellis SW; Troke PF
    J Med Vet Mycol; 1990; 28(4):327-34. PubMed ID: 2176687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger.
    Marichal P; Gorrens J; Vanden Bossche H
    Sabouraudia; 1985 Feb; 23(1):13-21. PubMed ID: 2986303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
    Dannaoui E; Persat F; Borel E; Piens MA; Picot S
    Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
    Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
    Xiong Q; Hassan SA; Wilson WK; Han XY; May GS; Tarrand JJ; Matsuda SP
    Antimicrob Agents Chemother; 2005 Feb; 49(2):518-24. PubMed ID: 15673727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
    Beach DH; Goad LJ; Holz GG
    Mol Biochem Parasitol; 1988 Nov; 31(2):149-62. PubMed ID: 2847043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
    Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
    Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.
    Long N; Xu X; Zeng Q; Sang H; Lu L
    Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterisation of ketoconazole inhibitory action on Aspergillus fumigatus.
    Venkateswarlu K; Kelly SL
    FEMS Immunol Med Microbiol; 1996 Nov; 16(1):11-20. PubMed ID: 8954348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergosterol biosynthesis pathway in Aspergillus fumigatus.
    Alcazar-Fuoli L; Mellado E; Garcia-Effron G; Lopez JF; Grimalt JO; Cuenca-Estrella JM; Rodriguez-Tudela JL
    Steroids; 2008 Mar; 73(3):339-47. PubMed ID: 18191972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
    Sardari S; Mori Y; Kurosawa T; Daneshtalab M
    Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Lipoxygenase inhibition by antifungal azole derivatives: new tools for immunosuppression?
    Jaschonek K; Steinhilber D; Einsele H; Ehninger G; Roth HJ
    Eicosanoids; 1989; 2(3):189-90. PubMed ID: 2560935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    Venkateswarlu K; Denning DW; Kelly SL
    J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
    Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
    J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three azole derivatives on the lipids of different strains of Cryptococcus neoformans.
    Franzot SP; Hamdan JS
    Mycoses; 1995; 38(5-6):183-9. PubMed ID: 8531929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
    Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
    Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three azole derivatives on the lipids of different strains of Sporothrix schenckii.
    Casali AK; Hamdan JS
    Can J Microbiol; 1997 Dec; 43(12):1197-202. PubMed ID: 9476355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.